39
Views
17
CrossRef citations to date
0
Altmetric
Review Article

Immunotoxins for Treatment of Leukemia and Lymphoma

&
Pages 195-201 | Received 12 Aug 1994, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yoav Messinger, Gregory H. Reaman, Onur Ek & Fatih M. Uckun. (1999) Evaluation of Temozolomide in a SCID Mouse Model of Human B-Cell Precursor Leukemia. Leukemia & Lymphoma 33:3-4, pages 289-293.
Read now
Roland Gunther, Lisa M. Chelstrom, Heather R. Wendorf, Elizabeth A. Schneider, Kristi Covalciuc, Bradley Johnson, Dina Clementson, James D. Irvin, Dorothea E. Myers & Fatih M. Uckun. (1996) Toxicity Profile of the Investigational New Biotherapeutic Agent, B43 (Anti-CD 19)-Pokeweed Antiviral Protein Immunotoxin. Leukemia & Lymphoma 22:1-2, pages 61-70.
Read now
Fatih M. Uckun, Gregory Reaman, Peter G. Steinherz, Diane C. Arthur, Harland Sather, Michael Trigg, David Tubergen & Paul Gaynon. (1996) Improved Clinical Outcome for Children with T-Lineage Acute Lymphoblastic Leukemia After Contemporary Chemotherapy: A Children's Cancer Group Study. Leukemia & Lymphoma 24:1-2, pages 57-70.
Read now

Articles from other publishers (13)

Barbara L. Asselin, Melissa M. Hudson & Louis S. Constine. 2010. Leibel and Phillips Textbook of Radiation Oncology. Leibel and Phillips Textbook of Radiation Oncology 1130 1169 .
Yoram Reiter & Avital Lev. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Ira Pastan, Raffit Hassan, David J. FitzGerald & Robert J. Kreitman. (2006) Immunotoxin therapy of cancer. Nature Reviews Cancer 6:7, pages 559-565.
Crossref
Patrizia Comoli & Cliona Rooney. 2006. Epstein-Barr Virus. Epstein-Barr Virus 353 374 .
Andishe Attarbaschi, Michael Dworzak, Manuel Steiner, Christian Urban, Franz-Martin Fink, Alfred Reiter, Helmut Gadner & Georg Mann. (2005) Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: A population-based analysis of the Austrian cooperative study group. Pediatric Blood & Cancer 44:1, pages 70-76.
Crossref
Shailendra K. Saxena, Kuslima Shogen & Wojciech Ardelt. (2003) ONCONASE® and Its Therapeutic Potential. Laboratory Medicine 34:5, pages 380-387.
Crossref
Kuslima Shogen, PhD, Shailendra K. Saxena, PhD & Wojciech Ardelt, PhD. (2003) ONCONASE ® and Its Therapeutic Potential. Laboratory Medicine 34:5, pages 380-387.
Crossref
Dianne L. NewtonHans J. HansenStanislaw M. MikulskiDavid M. GoldenbergSusanna M. Rybak. (2001) Potent and specific antitumor effects of an anti-CD22–targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood 97:2, pages 528-535.
Crossref
Francis Rajamohan, Sekou O. Doumbia, Cherri R. Engstrom, Sharon L. Pendergras, Daniell L. Maher & Fatih M. Uckun. (2000) Expression of Biologically Active Recombinant Pokeweed Antiviral Protein in Methylotrophic Yeast Pichia pastoris. Protein Expression and Purification 18:2, pages 193-201.
Crossref
Francis Rajamohan, Cherri R. Engstrom, Tammy J. Denton, Lisa A. Engen, Igor Kourinov & Fatih M. Uckun. (1999) High-Level Expression and Purification of Biologically Active Recombinant Pokeweed Antiviral Protein. Protein Expression and Purification 16:2, pages 359-368.
Crossref
Alessandro RambaldiGianmaria BorleriGianpietro DottiPiermario BellavitaRicardo AmaruAndrea BiondiTiziano Barbui. (1998) Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor–Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation. Blood 91:6, pages 2189-2196.
Crossref
John T. Sandlund, James R. Downing & William M. Crist. (1996) Non-Hodgkin's Lymphoma in Childhood. New England Journal of Medicine 334:19, pages 1238-1248.
Crossref
F. M. UckunW. E. EvansC. J. ForsythK. G. WaddickL. Tuel-AhlgrenL. M. ChelstromA. BurkhardtJ. BolenD. E. Myers. (1995) Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267:5199, pages 886-891.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.